We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.71B
AUM Growth
-$105M
Cap. Flow
-$29.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23

Top Buys

Rank Stock Value
1
GXO icon
GXO Logistics
GXO
+$23.9M
2
SNBR
Sleep Number
SNBR
+$17.4M
3
BBBY
Bed Bath & Beyond
BBBY
+$7.08M
4
IAA
IAA, Inc. Common Stock
IAA
+$5.96M
5
BVS icon
Bioventus
BVS
+$5.71M

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$20.8M
2
ZD icon
Ziff Davis
ZD
+$9.39M
3
NKTR icon
Nektar Therapeutics
NKTR
+$8.49M
4
POOL icon
Pool Corp
POOL
+$7.21M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$7.06M

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 24.54%
3 Industrials 15.71%
4 Consumer Discretionary 13.79%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSOD
51
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$16.8M 0.62%
293,079
-7,074
-2% -$384K
SNBR
52
DELISTED
Sleep Number
SNBR
$16.4M 0.6%
+174,976
New +$17.4M
ALBO
53
DELISTED
Albireo Pharma Inc
ALBO
$15.8M 0.59%
507,681
-2,786
-0.5% -$86.2K
FATE icon
54
Fate Therapeutics
FATE
$326M
$15.5M 0.57%
260,756
-74,671
-22% -$5.86M
COLL icon
55
Collegium Pharmaceutical
COLL
$956M
$14.9M 0.55%
753,038
-46,260
-6% -$1M
TFX icon
56
Teleflex
TFX
$5.98B
$14.7M 0.54%
39,102
-2,664
-6% -$1.04M
ARNA
57
DELISTED
Arena Pharmaceuticals Inc
ARNA
$14.6M 0.54%
245,395
-6,021
-2% -$356K
FC icon
58
Franklin Covey
FC
$246M
$14.4M 0.53%
352,547
+3,404
+1% +$131K
PCOM
59
DELISTED
Points.com Inc. Common Shares
PCOM
$14.3M 0.53%
836,122
+11,525
+1% +$198K
AERI
60
DELISTED
Aerie Pharmaceuticals
AERI
$14.1M 0.52%
1,232,600
-8,083
-0.7% -$118K
LMAT icon
61
LeMaitre Vascular
LMAT
$1.86B
$13.4M 0.49%
252,269
+4,393
+2% +$247K
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
$12.5M 0.46%
823,283
+294,311
+56% +$4.6M
ASND icon
63
Ascendis Pharma A/S
ASND
$16.8B
$12.2M 0.45%
76,766
+36,593
+91% +$5.01M
RETA
64
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11.6M 0.43%
114,806
-2,843
-2% -$333K
UTMD icon
65
Utah Medical Products
UTMD
$225M
$10.7M 0.39%
114,785
+1,896
+2% +$167K
AAP icon
66
Advance Auto Parts
AAP
$3.49B
$10.5M 0.39%
50,429
-3,435
-6% -$716K
GBT
67
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10.4M 0.39%
409,781
+61,162
+18% +$1.8M
CSGP icon
68
CoStar Group
CSGP
$12.3B
$10.4M 0.38%
120,636
-8,101
-6% -$700K
CSW
69
CSW Industrials
CSW
$5.71B
$9.91M 0.37%
77,603
+1,813
+2% +$226K
ITRN icon
70
Ituran Location and Control
ITRN
$1.05B
$9.43M 0.35%
371,243
+18,937
+5% +$484K
KNSA icon
71
Kiniksa Pharmaceuticals
KNSA
$5.93B
$8.4M 0.31%
737,374
+3,008
+0.4% +$39.2K
ACAD icon
72
Acadia Pharmaceuticals
ACAD
$5.03B
$8.25M 0.3%
496,757
-16,125
-3% -$311K
KPTI icon
73
Karyopharm Therapeutics
KPTI
$48M
$8.16M 0.3%
93,457
-503
-0.5% -$52.2K
INSM icon
74
Insmed
INSM
$28.6B
$8.06M 0.3%
292,801
-7,771
-3% -$204K
MSM icon
75
MSC Industrial Direct
MSM
$6.86B
$7.68M 0.28%
95,812
-2,426
-2% -$206K
1 2
3
4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
  • Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
  • Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
  • Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
  • Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.